QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dostatni, N Articles by Yaniv, M Search for Related Content PubMed PubMed Citation Articles by Dostatni, N Articles by Yaniv, M Social Bookmarking                   What's this?

Research Papers

The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex.

Département des Biotechnologies, UA 1149 du Centre National de la Recherche Scientifique, Institut Pasteur, Paris, France.

Abstract

The products encoded by the E2 open reading frame of the papillomaviruses are DNA-binding transcription factors involved in the positive or negative regulation of multiple viral promoters. To further understand the mechanisms by which the same transcription factor may act differentially, the full-length BPV-1 E2 protein was expressed and purified from yeast and assayed in vitro for its capacity to modulate transcription. E2 stimulated transcription of the HSV thymidine kinase (TK) promoter when E2-binding sites were positioned in an enhancer configuration approximately 100 bp upstream of the promoter start site. In contrast, the same full-length E2 protein repressed transcription of the HPV-18 E6/E7 P105 promoter. This repression was mediated through binding to the E2 DNA-binding site immediately upstream of the P105 promoter TATA box and could be abrogated by preincubation of the HPV-18 P105 promoter template with the nuclear extract allowing the formation of the preinitiation complex. In vitro DNA-binding experiments with purified E2 and TFIID showed that binding of E2 to its DNA target placed at different positions with respect to the TATA box differentially affects binding of TFIID to its cognate site. In these respects, E2 is similar to the bacteriophage lambda repressor, which can act either as a repressor or an activator of transcription depending on the position of its binding sites relative to the promoter sequences.

CiteULike

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				R. Ajay Kumar, S. R. Naidu, X. Wang, A. N. Imbalzano, and E. J. Androphy Interaction of Papillomavirus E2 Protein with the Brm Chromatin Remodeling Complex Leads to Enhanced Transcriptional Activation J. Virol., March 1, 2007; 81(5): 2213 - 2220. [Abstract] [Full Text] [PDF]

				K. Handa, T. Yugawa, M. Narisawa-Saito, S.-i. Ohno, M. Fujita, and T. Kiyono E6AP-Dependent Degradation of DLG4/PSD95 by High-Risk Human Papillomavirus Type 18 E6 Protein J. Virol., February 1, 2007; 81(3): 1379 - 1389. [Abstract] [Full Text] [PDF]

				S.-Y. Wu, A-Y. Lee, S. Y. Hou, J. K. Kemper, H. Erdjument-Bromage, P. Tempst, and C.-M. Chiang Brd4 links chromatin targeting to HPV transcriptional silencing Genes & Dev., September 1, 2006; 20(17): 2383 - 2396. [Abstract] [Full Text] [PDF]

				K. Imai and T. Okamoto Transcriptional Repression of Human Immunodeficiency Virus Type 1 by AP-4 J. Biol. Chem., May 5, 2006; 281(18): 12495 - 12505. [Abstract] [Full Text] [PDF]

				S. Blachon, S. Bellanger, C. Demeret, and F. Thierry Nucleo-cytoplasmic Shuttling of High Risk Human Papillomavirus E2 Proteins Induces Apoptosis J. Biol. Chem., October 28, 2005; 280(43): 36088 - 36098. [Abstract] [Full Text] [PDF]

				M. S. Longworth and L. A. Laimins Pathogenesis of Human Papillomaviruses in Differentiating Epithelia Microbiol. Mol. Biol. Rev., June 1, 2004; 68(2): 362 - 372. [Abstract] [Full Text] [PDF]

				K. Kim, P. A. Garner-Hamrick, C. Fisher, D. Lee, and P. F. Lambert Methylation Patterns of Papillomavirus DNA, Its Influence on E2 Function, and Implications in Viral Infection J. Virol., December 1, 2003; 77(23): 12450 - 12459. [Abstract] [Full Text] [PDF]

				W. Deng, G. Jin, B.-Y. Lin, B. A. Van Tine, T. R. Broker, and L. T. Chow mRNA Splicing Regulates Human Papillomavirus Type 11 E1 Protein Production and DNA Replication J. Virol., October 1, 2003; 77(19): 10213 - 10226. [Abstract] [Full Text] [PDF]

				V. Bechtold, P. Beard, and K. Raj Human Papillomavirus Type 16 E2 Protein Has No Effect on Transcription from Episomal Viral DNA J. Virol., February 1, 2003; 77(3): 2021 - 2028. [Abstract] [Full Text] [PDF]

				S. Y. Hou, S.-Y. Wu, and C.-M. Chiang Transcriptional Activity among High and Low Risk Human Papillomavirus E2 Proteins Correlates with E2 DNA Binding J. Biol. Chem., November 15, 2002; 277(47): 45619 - 45629. [Abstract] [Full Text] [PDF]

				K.-N. Zhao and I. H. Frazer Saccharomyces cerevisiae Is Permissive for Replication of Bovine Papillomavirus Type 1 J. Virol., October 25, 2002; 76(23): 12265 - 12273. [Abstract] [Full Text] [PDF]

				K. A. Hartley and K. A. Alexander Human TATA Binding Protein Inhibits Human Papillomavirus Type 11 DNA Replication by Antagonizing E1-E2 Protein Complex Formation on the Viral Origin of Replication J. Virol., April 16, 2002; 76(10): 5014 - 5023. [Abstract] [Full Text] [PDF]

				S. Bellanger, C. Demeret, S. Goyat, and F. Thierry Stability of the Human Papillomavirus Type 18 E2 Protein Is Regulated by a Proteasome Degradation Pathway through Its Amino-Terminal Transactivation Domain J. Virol., August 15, 2001; 75(16): 7244 - 7251. [Abstract] [Full Text] [PDF]

				F. Stubenrauch, T. Zobel, and T. Iftner The E8 Domain Confers a Novel Long-Distance Transcriptional Repression Activity on the E8^E2C Protein of High-Risk Human Papillomavirus Type 31 J. Virol., May 1, 2001; 75(9): 4139 - 4149. [Abstract] [Full Text]

				C. Kämmer, U. Warthorst, N. Torrez-Martinez, C. M. Wheeler, and H. Pfister Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity J. Gen. Virol., August 1, 2000; 81(8): 1975 - 1981. [Abstract] [Full Text]

				W. H. Kao, S. L. Beaudenon, A. L. Talis, J. M. Huibregtse, and P. M. Howley Human Papillomavirus Type 16 E6 Induces Self-Ubiquitination of the E6AP Ubiquitin-Protein Ligase J. Virol., July 15, 2000; 74(14): 6408 - 6417. [Abstract] [Full Text]

				A. Nishimura, T. Ono, A. Ishimoto, J. J. Dowhanick, M. A. Frizzell, P. M. Howley, and H. Sakai Mechanisms of Human Papillomavirus E2-Mediated Repression of Viral Oncogene Expression and Cervical Cancer Cell Growth Inhibition J. Virol., April 15, 2000; 74(8): 3752 - 3760. [Abstract] [Full Text]

				N. Zou, B. Y. Lin, F. Duan, K.-Y. Lee, G. Jin, R. Guan, G. Yao, E. J. Lefkowitz, T. R. Broker, and L. T. Chow The Hinge of the Human Papillomavirus Type 11 E2 Protein Contains Major Determinants for Nuclear Localization and Nuclear Matrix Association J. Virol., April 15, 2000; 74(8): 3761 - 3770. [Abstract] [Full Text]

				D. A. Francis, S. I. Schmid, and P. M. Howley Repression of the Integrated Papillomavirus E6/E7 Promoter Is Required for Growth Suppression of Cervical Cancer Cells J. Virol., March 15, 2000; 74(6): 2679 - 2686. [Abstract] [Full Text]

				S. Y. Hou, S.-Y. Wu, T. Zhou, M. C. Thomas, and C.-M. Chiang Alleviation of Human Papillomavirus E2-Mediated Transcriptional Repression via Formation of a TATA Binding Protein (or TFIID)-TFIIB-RNA Polymerase II-TFIIF Preinitiation Complex Mol. Cell. Biol., January 1, 2000; 20(1): 113 - 125. [Abstract] [Full Text]

				R. Kovelman, G. K. Bilter, A. Roman, D. R. Brown, and M. S. Barbosa Human papillomavirus type 6: classification of clinical isolates and functional analysis of E2 proteins J. Gen. Virol., September 1, 1999; 80(9): 2445 - 2451. [Abstract] [Full Text]

				H. Lewis, K. Webster, A.-M. Sanchez-Perez, and K. Gaston Cellular transcription factors regulate human papillomavirus type 16 gene expression by binding to a subset of the DNA sequences recognized by the viral E2 protein J. Gen. Virol., August 1, 1999; 80(8): 2087 - 2096. [Abstract] [Full Text]

				K.-Y. Lee, T. R. Broker, and L. T. Chow Transcription Factor YY1 Represses Cell-Free Replication from Human Papillomavirus Origins J. Virol., June 1, 1998; 72(6): 4911 - 4917. [Abstract] [Full Text] [PDF]

				E. C. Goodwin, L. K. Naeger, D. E. Breiding, E. J. Androphy, and D. DiMaio Transactivation-Competent Bovine Papillomavirus E2 Protein Is Specifically Required for Efficient Repression of Human Papillomavirus Oncogene Expression and for Acute Growth Inhibition of Cervical Carcinoma Cell Lines J. Virol., May 1, 1998; 72(5): 3925 - 3934. [Abstract] [Full Text] [PDF]

				M. A. Ozbun and C. Meyers Temporal Usage of Multiple Promoters during the Life Cycle of Human Papillomavirus Type 31b J. Virol., April 1, 1998; 72(4): 2715 - 2722. [Abstract] [Full Text] [PDF]

				F. Stubenrauch, H. B. Lim, and L. A. Laimins Differential Requirements for Conserved E2 Binding Sites in the Life Cycle of Oncogenic Human Papillomavirus Type 31 J. Virol., February 1, 1998; 72(2): 1071 - 1077. [Abstract] [Full Text] [PDF]

				A. Shilatifard, D. Haque, R. C. Conaway, and J. W. Conaway Structure and Function of RNA Polymerase II Elongation Factor ELL. IDENTIFICATION OF TWO OVERLAPPING ELL FUNCTIONAL DOMAINS THAT GOVERN ITS INTERACTION WITH POLYMERASE AND THE TERNARY ELONGATION COMPLEX J. Biol. Chem., August 29, 1997; 272(35): 22355 - 22363. [Abstract] [Full Text] [PDF]

				A. Thain, K. Webster, D. Emery, A. R. Clarke, and K. Gaston DNA Binding and Bending by the Human Papillomavirus Type 16E2 Protein. RECOGNITION OF AN EXTENDED BINDING SITE J. Biol. Chem., March 28, 1997; 272(13): 8236 - 8242. [Abstract] [Full Text] [PDF]

				D Falb and T Maniatis A conserved regulatory unit implicated in tissue-specific gene expression in Drosophila and man. Genes & Dev., March 1, 1992; 6(3): 454 - 465. [Abstract] [PDF]